HPMA copolymers containing doxorubicin bound by a proteolytically or hydrolytically cleavable bond: comparison of biological properties in vitro
- 1 September 2004
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 99 (2) , 301-314
- https://doi.org/10.1016/j.jconrel.2004.07.015
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Differences in the intracellular fate of free and polymer-bound doxorubicinJournal of Controlled Release, 2002
- In Vitro and In Vivo Effect of HPMA Copolymer-bound Doxorubicin Targeted to Transferrin Receptor of B-cell Lymphoma 38C13Journal of Drug Targeting, 2002
- A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicinBiochemical Pharmacology, 1999
- Targeting of human and mouse T-lymphocytes by monoclonal antibody-HPMA copolymer–doxorubicin conjugates directed against different T-cell surface antigensJournal of Controlled Release, 1998
- Polymeric Drug-Carriers Containing Doxorubicin and Melanocyte-Stimulating Hormone:In VitroandIn VivoEvaluation Against Murine MelanomaJournal of Drug Targeting, 1993
- Polymers containing enzymatically degradable bonds, XII. Effect of spacer structure on the rate of release of daunomycin and adriamycin from poly [N-(2-hydroxypropyl)-methacrylamide] copolymer drag carriers in vitro and antitumour activity measured in vivoJournal of Controlled Release, 1992
- Liposomes as carriers of antitumor agents: Toward a clinical realityCancer Treatment Reviews, 1989
- Antibody-directed affinity therapy applied to the immune system: In vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymers and targeting antibodyClinical Immunology and Immunopathology, 1988
- Biological properties of targetable poly[N-(2-hydroxypropyl)-methacrylamide]-antibody conjugatesJournal of Controlled Release, 1985
- Characterization of a carcinogen‐induced murine B lymphocyte cell line of C3H/eB originEuropean Journal of Immunology, 1977